Odonate Inc
Change company Symbol lookup
Select an option...
ODTC Odonate Inc
MMV MultiMetaVerse Holdings Limited
BAC Bank of America Corp
XPL Solitario Zinc Corp
DD Dupont De Nemours Inc
RLJ RLJ Lodging Trust
TTEXF Bullion Gold Resources Corp
FRLN Freeline Therapeutics Holdings PLC
PCQ PIMCO California Municipal Income Fund
WULF Terawulf Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.

Closing Price
$1.80
Day's Change
-0.01 (-0.55%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.81
Day's Low
1.80
Volume
(Heavy Day)
Volume:
64,568

10-day average volume:
11,203
64,568

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.